Development of lymphoid hyperplasia in transgenic mice expressing the HIV tat gene

AIDS Res Hum Retroviruses. 1995 Jan;11(1):21-9. doi: 10.1089/aid.1995.11.21.

Abstract

During HIV infection, individuals experience multiorgan disorders such as adenopathy, splenomegaly, and lung and brain diseases. There is an increasing body of evidence that the HIV trans-activating tat gene product possesses multiple activities. First, it can activate several cellular genes; second, in its extracellular soluble form, it plays the role of growth factor in some cells such as Kaposi's sarcoma cells. Thus, we introduced the HIV tat gene, under the control of the cellular proteolipoprotein promoter, into the germline of mice and demonstrate that, when expressed, the tat gene product induces lymphoid hyperplasia in spleen, lymph nodes, and lung, as is observed in AIDS patients, but not in the brain or testes. Our findings indicate that HIV, through some of its genes, directly participates in the pathogenesis of AIDS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Base Sequence
  • DNA, Complementary
  • Gene Expression Regulation, Viral
  • Gene Products, tat / genetics*
  • Gene Products, tat / metabolism
  • HIV / genetics*
  • Hyperplasia / genetics
  • Lung / pathology*
  • Lymph Nodes / pathology*
  • Mice
  • Mice, Transgenic
  • Molecular Sequence Data
  • Organ Specificity
  • RNA / analysis
  • Spleen / pathology*
  • tat Gene Products, Human Immunodeficiency Virus

Substances

  • DNA, Complementary
  • Gene Products, tat
  • tat Gene Products, Human Immunodeficiency Virus
  • RNA